Skip to main content
Top
Published in: International Journal of Hematology 5/2020

01-11-2020 | Lymphoma | Case Report

HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders

Authors: Sandra Sanchez, Luis Veloza, Luojun Wang, Mónica López, Armando López-Guillermo, Marta Marginet, Antonio Martínez, Olga Balagué, Elias Campo

Published in: International Journal of Hematology | Issue 5/2020

Login to get access

Abstract

Human herpesvirus type 8 (HHV8) is a gamma herpesvirus known for its role in lymphoid neoplasms, especially in immunosuppressed patients. We describe the case of a 64-year-old male, without known immunodeficiency, with 1-year-long clinical history of mediastinal and abdominal lymphadenopathies and recurrent pulmonary infections. Histopathological evaluation of a mediastinal lymph node revealed the presence of scattered atypical large cells with Hodgkin and Reed–Sternberg morphology in a background of lymphocytes and extensive areas of fibrosis. The large cells were positive for HHV8 and Epstein–Barr virus (EBV), with a clonal pattern of IGH gene rearrangement. A descriptive diagnosis of “HHV8-positive, EBV-positive Hodgkin lymphoma-like large B-cell lymphoma” was rendered. Interestingly, the retrospective evaluation of a previous biopsy, diagnosed as reactive lymphadenitis, revealed the presence of HHV8- and EBV-positive cells, with a polyclonal pattern and a small peak corresponding to that of the most recent biopsy. This case presents diagnostic challenges due to the presence of particular features not clearly related to current HHV8-associated entities, and also suggests the possibility for disease progression in the spectrum of HHV8- and EBV-associated lymphoproliferative disorders.
Literature
1.
go back to reference Cathomas G. Kaposi’s sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus. Herpes: J IHMF. 2003;10(3):72–7. Cathomas G. Kaposi’s sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus. Herpes: J IHMF. 2003;10(3):72–7.
2.
go back to reference Stebbing J, Pantanowitz L, Dayyani F, Sullivan RJ, Bower M, Dezube BJ. HIV associated multicentric Castleman’s disease. Am J Hematol. 2008;83(6):498–503.CrossRef Stebbing J, Pantanowitz L, Dayyani F, Sullivan RJ, Bower M, Dezube BJ. HIV associated multicentric Castleman’s disease. Am J Hematol. 2008;83(6):498–503.CrossRef
3.
go back to reference Ariza-Heredia EJ, Razonable RR. Human herpes virus 8 in solid organ transplantation. Transplantation. 2011;92(8):837–44.CrossRef Ariza-Heredia EJ, Razonable RR. Human herpes virus 8 in solid organ transplantation. Transplantation. 2011;92(8):837–44.CrossRef
4.
go back to reference Said J, Isaacson PG, Campo E, Harris NL. HHV8-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition). Lyon: IARC Press; 2017. p. 325–9. Said J, Isaacson PG, Campo E, Harris NL. HHV8-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition). Lyon: IARC Press; 2017. p. 325–9.
5.
go back to reference Courville EL, Sohani AR, Hasserjian RP, Zukerberg LR, Harris NL, Ferry JA. Diverse clinicopathologic features in human herpesvirus 8-associated lymphomas lead to diagnostic problems. Am J Clin Pathol. 2014;142(6):816–29.CrossRef Courville EL, Sohani AR, Hasserjian RP, Zukerberg LR, Harris NL, Ferry JA. Diverse clinicopathologic features in human herpesvirus 8-associated lymphomas lead to diagnostic problems. Am J Clin Pathol. 2014;142(6):816–29.CrossRef
6.
go back to reference Seliem RM, Griffith RC, Harris NL, Beheshti J, Schiffman FJ, Longtine J, et al. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ man: the spectrum of HHV-8+ lymphoproliferative disorders expands. Am J Surg Pathol. 2007;31(9):1439–45.CrossRef Seliem RM, Griffith RC, Harris NL, Beheshti J, Schiffman FJ, Longtine J, et al. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ man: the spectrum of HHV-8+ lymphoproliferative disorders expands. Am J Surg Pathol. 2007;31(9):1439–45.CrossRef
7.
go back to reference Gonzalez-Farre B, Martinez D, Lopez-Guerra M, Xipell M, Monclus E, Rovira J, et al. HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma. Mod Pathol. 2017;30(5):745–60.CrossRef Gonzalez-Farre B, Martinez D, Lopez-Guerra M, Xipell M, Monclus E, Rovira J, et al. HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma. Mod Pathol. 2017;30(5):745–60.CrossRef
8.
go back to reference Ferry JA, Sohani AR, Longtine JA, Schwartz RA, Harris NL. HHV8-positive, EBV positive Hodgkin lymphoma-like large B-cell lymphoma and HHV8-positive intravascular large B-cell lymphoma. Mod Pathol. 2009;22(5):618–26.CrossRef Ferry JA, Sohani AR, Longtine JA, Schwartz RA, Harris NL. HHV8-positive, EBV positive Hodgkin lymphoma-like large B-cell lymphoma and HHV8-positive intravascular large B-cell lymphoma. Mod Pathol. 2009;22(5):618–26.CrossRef
9.
go back to reference Bhavsar T, Lee JC, Perner Y, Raffeld M, Xi L, Pittaluga S, et al. KSHV-associated and EBV-associated germinotropic lymphoproliferative disorder: new findings and review of the literature. Am J Surg Pathol. 2017;41(6):795–800.CrossRef Bhavsar T, Lee JC, Perner Y, Raffeld M, Xi L, Pittaluga S, et al. KSHV-associated and EBV-associated germinotropic lymphoproliferative disorder: new findings and review of the literature. Am J Surg Pathol. 2017;41(6):795–800.CrossRef
10.
go back to reference Veloza L, Teixido C, Castrejon N, Climent F, Carrio A, Marginet M, et al. Clinicopathological evaluation of PD1/PD-L1 axis in post-transplant lymphoproliferative disorders: association with EBV, PD-L1 copy number alterations and outcome. Histopathology. 2019;75(6):799–812.CrossRef Veloza L, Teixido C, Castrejon N, Climent F, Carrio A, Marginet M, et al. Clinicopathological evaluation of PD1/PD-L1 axis in post-transplant lymphoproliferative disorders: association with EBV, PD-L1 copy number alterations and outcome. Histopathology. 2019;75(6):799–812.CrossRef
11.
go back to reference Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Philos Trans R Soc Lond Ser B Biol Sci. 2017;372(1732):20160271.CrossRef Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Philos Trans R Soc Lond Ser B Biol Sci. 2017;372(1732):20160271.CrossRef
12.
go back to reference Said J, Cesarman E. Primary effusion lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition). Lyon: IARC Press; 2017. p. 323–4. Said J, Cesarman E. Primary effusion lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition). Lyon: IARC Press; 2017. p. 323–4.
13.
go back to reference Carbone A. KSHV/HHV-8 associated Kaposi’s sarcoma in lymph nodes concurrent with Epstein-Barr virus associated Hodgkin lymphoma. J Clin Pathol. 2005;58(6):626–8.CrossRef Carbone A. KSHV/HHV-8 associated Kaposi’s sarcoma in lymph nodes concurrent with Epstein-Barr virus associated Hodgkin lymphoma. J Clin Pathol. 2005;58(6):626–8.CrossRef
14.
go back to reference Girndt M, Sester U, Sester M, Kaul H, Köhler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transpl. 1999;14(12):2807–10.CrossRef Girndt M, Sester U, Sester M, Kaul H, Köhler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transpl. 1999;14(12):2807–10.CrossRef
15.
go back to reference Chen BJ, Chapuy B, Ouyang J, Sun HH, Roemer MG, Xu ML, et al. PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus associated malignancies. Clin Cancer Res. 2013;19(13):3462–73.CrossRef Chen BJ, Chapuy B, Ouyang J, Sun HH, Roemer MG, Xu ML, et al. PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus associated malignancies. Clin Cancer Res. 2013;19(13):3462–73.CrossRef
16.
go back to reference Guerrero C, Jain T, Kelemen K. HHV-8-associated lymphoproliferative disorders and pathogenesis in an HIV-positive patient. Case Rep Hematol. 2019;2019:4536157.PubMedPubMedCentral Guerrero C, Jain T, Kelemen K. HHV-8-associated lymphoproliferative disorders and pathogenesis in an HIV-positive patient. Case Rep Hematol. 2019;2019:4536157.PubMedPubMedCentral
Metadata
Title
HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders
Authors
Sandra Sanchez
Luis Veloza
Luojun Wang
Mónica López
Armando López-Guillermo
Marta Marginet
Antonio Martínez
Olga Balagué
Elias Campo
Publication date
01-11-2020
Publisher
Springer Singapore
Published in
International Journal of Hematology / Issue 5/2020
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-020-02897-8

Other articles of this Issue 5/2020

International Journal of Hematology 5/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine